We use cookies for a better user experience. Read our Privacy Policy

I Agree

Multiplex Detection Immunoassays Market

Multiplex Detection Immunoassays Market (Assay Type: Planar Assay and Bead-based Assay; Technique: Nucleic Acid-based Techniques, Protein-based Techniques, and Biosensor-based Techniques; Application: Disease Testing, Food Contamination Testing, Research & Development, and Veterinary Disease Testing; and End User: Pharmaceutical & Biopharmaceutical Companies, Clinical Research Organizations, Food & Beverages Industry, Academic & Research Institutes, Diagnostic Centers, and Others) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

Immunoassays Gain Popularity as Food and Environmental Protection Prioritized

Over the past few decades, food contamination caused by antibiotic residues has emerged as a global issue mainly caused by the improper usage of antibiotics. At present, the development of easy, high-throughput, cost-effective, and rapid screening techniques for the detection of antibiotic residues has gained considerable momentum due to the increasing need to find alternatives for conventional assays– a factor that is expected to boost the growth of the global multiplex detection immunoassays market during the forecast period. Moreover, immunoassays are gaining popularity as a promising evaluation technique for environmental and food protection. This is likely to accelerate innovations across the global multiplex detection immunoassays market.

At present, a number of players involved in the current global multiplex detection immunoassays market landscape is increasingly focusing on the development of different types of multiplex detection immunoassays such as radioimmunoassay, colloidal gold immunoassay, enzyme-linked immunoassay, and chemiluminescence immunoassays among others to swiftly detect antibiotic residues. Market players are projected to focus on improving the performance of multiplex detection immunoassays to establish a solid foothold in the competitive landscape. The demand for screening of antibiotic residues is anticipated to witness a considerable spike, particularly in the first half of the forecast due to the outbreak of the COVID-19 pandemic. This is likely to aid the growth of the global multiplex detection immunoassays market.

At the back of these factors, along with a surge in the number of research and development activities, the global multiplex detection immunoassays market is on the course to surpass US$ 3.65 Bn mark by the end of 2030.

Request a sample to get extensive insights into the Multiplex Detection Immunoassays Market

Rise in Demand for Clinical Diagnosis Applications to Propel Market Growth

Multiplex detection immunoassays are increasingly being used in a wide range of applications, including infectious disease testing, food contamination testing, veterinary disease testing, and R&D activities. The increasing demand for multiplex detection immunoassays for clinical diagnosis is expected to accelerate the development of multiplex detection immunoassays in the upcoming years– a factor that is set to fuel the growth of the market for global multiplex detection immunoassays during the assessment period. Prosthetic joint replacements are primarily used to enhance the quality of life, restore the joint function, and improve mobility. Although prosthetic joint replacement is a globally accepted treatment, prosthetic joint infection is one of the major causes of knee arthroplasties, which makes early diagnosis critical. This is set to drive the demand for multiplex detection immunoassays.

As a measure to prevent prosthetic joint infection, a number of immunoassays are available to assist in the early detection of infections out of which, lateral flow multiplex detection immunoassay is at the forefront in terms of adoption due to the low-costs, speed, and simplicity.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Point-of-care Testing to Aid Market Growth

The noteworthy surge in the demand for point of care diagnostic devices for rapid initial screening in various non-laboratory setting is another factor that is anticipated to provide a considerable boost to the growth of the global multiplex detection immunoassays market during the assessment period. The demand for ‘near-patient tests’ is on the rise, owing to its high patient convenience. Some of the most widely used point-of-care tests include blood glucose tests, drug screenings, and food pathogens. At present, a range of point-of-care immunoassays is available to determine the presence of various pathogens and substances, and efforts are being made to improve the quality and performance of the same, thus driving the multiplex detection immunoassays market during the assessment period.

Researchers Focus on Development of Multiplex Immunoassay for Simultaneous Detection of Human Coronaviruses

The outbreak of the COVID-19 pandemic is projected to have a strong impact on the growth of the global multiplex detection immunoassays market. Research and development activities are expected to gain considerable traction across the global multiplex detection immunoassays market during the ongoing COVID-19 health crisis. At present, scientists and researchers are increasingly focusing on the development of multiplex serologic assays to enable swift detection and surveillance of known human coronaviruses. Research and development activities are anticipated to set the tone for the growth of the global multiplex detection immunoassays market in the upcoming years.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Multiplex Detection Immunoassays Market

Analysts’ Viewpoint

The global multiplex detection immunoassays market is anticipated to grow at a healthy CAGR of 7.5% during the forecast period. The market growth is primarily driven by a host of factors, including increasing need for swift and early detection of antibiotic residues for food and environmental protection, significant rise in the prevalence of infectious and chronic diseases, and increase in emphasis on research and development. The outbreak of the COVID-19 pandemic will play a key role in accelerating research and development activities, as researchers and scientists continue to leverage multiplex detection immunoassays for the detection of human coronaviruses worldwide.

Multiplex Detection Immunoassays Market: Overview

  • According to Transparency Market Research’s latest research report on the global multiplex detection immunoassays market for the historical period (2018–2019) and the forecast period (2020–2030), high prevalence and increase in incidence rate of chronic and infectious diseases are projected to drive the global multiplex detection immunoassays market in the near future
  • According to the report, the global multiplex detection immunoassays market was valued at US$ 1.5 Bn in 2019 and is anticipated to expand at a CAGR of 7.5% from 2020 to 2030

High Prevalence and Increase in Incidence Rate of Chronic and Infectious Diseases: Key Driver of Multiplex Detection Immunoassays Market

  • Diagnosis of infectious and chronic diseases is a leading application of in vitro diagnostics. Life science reagents (both biological and chemical) are an integral and vital part of any diagnostic test. The emergence and outbreak of various infectious diseases has created challenges and opportunities for researchers to develop new diagnostic tools and tests for early diagnosis and prevention of diseases.
  • According to the World Health Organization (WHO), chronic diseases are projected to account for nearly three-quarters of all deaths globally in 2020, with 71% of deaths due to ischemic heart disease (IHD), 75% due to stroke, and 70% owing to diabetes likely to occur in developing countries. The number of people with diabetes in the developing countries is estimated to increase by over 2.5 times, from 84 million in 1995 to 228 million in 2025.
  • Globally, 60% of the burden of chronic diseases is projected to occur in developing countries. Prevalence of cardiovascular diseases is higher in India and China than in all the economically developed countries in the world put together.
  • According to the WHO, chronic disease prevalence is expected to rise by 57% by 2020. Healthcare expenditure increases, sometimes exponentially, with each additional chronic condition with greater specialist physician access, emergency department presentations, and hospital admissions.
  • Chronic and infectious diseases have been a major driver of healthcare costs, while also impacting workforce patterns, including absenteeism. According to the Centers for Disease Control, in the U.S. alone, chronic diseases account for nearly 75% of aggregate healthcare spending, or an estimated US$ 5,300 per person annually.
  • According to the Centers for Disease Control and Prevention, 6 in 10 adults in the U.S. have a chronic disease. Chronic diseases are likely to affect an estimated 164 million people in the U.S., nearly half (49%) of the population of the country, by 2025. Prevention and management of chronic diseases are best performed by multidisciplinary teams in primary care and public health. According to Project HOPE: The People-to-People Health Foundation, Inc., the number of people with chronic mental disorders could increase from 30 million to 47 million, by 2023. Similar increases are projected for virtually every common chronic condition.

Laboratory Consolidation and Demand for Laboratory Integration and Automation: Key Driver of Multiplex Detection Immunoassays Market

  • Increase in operational costs, stringent rules and regulations, decrease in reimbursements, lack of quality workforce, and intense competition in the industry are the major challenges hospitals and diagnostic laboratories face currently
  • Cost per test and revenue of diagnostic laboratories have been declining in the past few years; however, the volume is projected to rise, owing to increase in geriatric population and surge in demand for preventive treatment and drug monitoring
  • Apart from economic constraints, other issues that small- and mid-volume laboratories face are quality and service issues, volatility in test volumes, and ad hoc test assays. Large laboratories are utilizing this opportunity to consolidate their position in the market.
  • Numerous global conglomerates are expanding their base in emerging regions through mergers and acquisitions in the clinical laboratories segment. Unilabs, a clinical laboratory conglomerate based in Switzerland, operates through 110 laboratories located in over 10 countries in Europe. Quest Diagnostics has presence in countries in Asia Pacific such as India and China. India-based SRL Diagnostics has presence in countries in South Africa and Southeast Asia.
  • Consolidation among laboratories is boosting test volumes, which is leading to the adoption of complete laboratory automation and integration. Large sample processing capacity, large parameters testing in short time, high throughput, minimum requirement of labor, integrated quality control & data storage, and integrated quality control and validation facility are the major factors projected to propel the global multiplex detection immunoassay market during the forecast period.

Multiplex Detection Immunoassays Market: Competition Landscape

  • This report profiles major players operating in the global multiplex detection immunoassays market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global multiplex detection immunoassays market is moderately fragmented, with the presence of a small number of leading players in the international market and several small players in regional markets. The top players hold major share of the global multiplex detection immunoassays market.
  • Prominent players operating in the global multiplex detection immunoassays market include
    • Hoffmann-La Roche Ltd
    • QIAGEN
    • Merck KGaA
    • Microsynth AG
    • Bio-Rad Laboratories
    • Thermo Fisher Scientific
    • Luminex Corporation
    • Becton
    • Dickinson and Company
  • The report on the global multiplex detection immunoassays market discusses individual strategies, followed by company profiles of manufacturers of multiplex detection immunoassays. The competition landscape section has been included in the report to provide readers with a dashboard view and company market share analysis of key players operating in the global multiplex detection immunoassays market.

Multiplex Detection Immunoassays Market – Segmentation

Assay Type

  • Planar Assay
  • Blends Protein Arrays (multiplexed ELISA)
  • Antibody Arrays
  • Bead-based Assay
  • Magnetic Bead-based
  • Non-magnetic Bead-based

Technique

  • Nucleic Acid-based Techniques
  • Protein-based Techniques
  • Biosensor-based Techniques

Application

  • Disease Testing
  • Infectious Disease Testing
  • Autoimmune Disease Testing
  • Other Diseases Testing
  • Food Contamination Testing
  • Research & Development
  • Veterinary Disease Testing

End User

  • Pharmaceutical & Biopharmaceutical Companies
  • Clinical Research Organizations
  • Food & Beverages Industry
  • Academic & Research Institutes
  • Diagnostic Centers
  • Others

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Interested in this report?
Get a FREE sample now!

Get Free Sample

*Get Sample Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of multiplex detection immunoassays market?

Multiplex detection immunoassays market to surpass valuation of US$ 3.65 Bn by 2030

What is the anticipated CAGR of the multiplex detection immunoassays market in the forecast period?

Multiplex detection immunoassays market is projected to expand at a CAGR of 7.5% from 2020 to 2030

What are the key driving factors for the growth of the multiplex detection immunoassays market?

Multiplex detection immunoassays market is driven by increase in incidence rate of chronic and infectious diseases

Which region is expected to project the highest market share in the global multiplex detection immunoassays market?

North America accounted for major share of the global multiplex detection immunoassays market

Who are the key players in the global multiplex detection immunoassays market?

Key players in the global multiplex detection immunoassays market include Hoffmann-La Roche Ltd., QIAGEN, Merck KGaA, Microsynth AG, Bio-Rad Laboratories

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Multiplex Detection Immunoassays Market

4. Market Overview

    4.1. Introduction

        4.1.1. Type Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Multiplex Detection Immunoassays Market Analysis and Forecast, 2018–2030

        4.4.1. Market Revenue Projections (US$ Mn)

    4.5. Porter’s Five Force Analysis

5. Key Insights

    5.1. Technological Advancement

    5.2. Key Mergers & Acquisitions

    5.3. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Multiplex Detection Immunoassays Market Analysis and Forecast, by Assay Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Assay Type, 2018–2030

        6.3.1. Planar Assays

            6.3.1.1. Blends Protein Arrays (multiplexed ELISA)

            6.3.1.2. Antibody Arrays

        6.3.2. Bead-based Assays

            6.3.2.1. Magnetic Bead-based

            6.3.2.2. Non-magnetic Bead-based

    6.4. Market Attractiveness Analysis, by Assay Type

7. Global Multiplex Detection Immunoassays Market Analysis and Forecasts, by Technique

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Technique, 2018–2030

        7.3.1. Nucleic Acid-based Techniques

        7.3.2. Protein-based Techniques

        7.3.3. Biosensor-based Techniques

    7.4. Market Attractiveness Analysis, by Technique

8. Global Multiplex Detection Immunoassays Market Analysis and Forecast, by Application

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by Application, 2018–2030

        8.3.1. Disease Testing

            8.3.1.1. Infectious Disease Testing

            8.3.1.2. Autoimmune Disease Testing

            8.3.1.3. Other Diseases Testing

        8.3.2. Food Contamination Testing

        8.3.3. Research & Development

        8.3.4. Veterinary Disease Testing

    8.4. Market Attractiveness Analysis, by Application

9. Global Multiplex Detection Immunoassays Market Analysis and Forecast, by End-user

    9.1.  Introduction & Definition

    9.2. Key Findings / Developments

    9.3. Market Value Forecast, by End-user, 2018–2030

        9.3.1. Pharmaceutical & Biopharmaceutical Companies

        9.3.2. Clinical Research Organizations

        9.3.3. Food & Beverage Industry

        9.3.4. Academic & Research Institutes

        9.3.5. Diagnostic Centers

        9.3.6. Others

    9.4.  Market Attractiveness Analysis, by End-user

10. Global Multiplex Detection Immunoassays Market Analysis and Forecasts, by Region

    10.1.  Key Findings

    10.2. Market Value Forecast, by Region

        10.2.1. North America

        10.2.2. Europe

        10.2.3.  Asia Pacific

        10.2.4.  Latin America

        10.2.5.  Middle East & Africa

    10.3.  Market Attractiveness Analysis, by Country/Region

11.  North America Multiplex Detection Immunoassays Market Analysis and Forecast

    11.1. Introduction

        11.1.1.  Key Findings

    11.2. Market Value Forecast, by Assay Type, 2018–2030

        11.2.1.  Planar Assays

            11.2.1.1.  Blends Protein Arrays (multiplexed ELISA)

            11.2.1.2.  Antibody Arrays

        11.2.2.  Bead-based Assays

            11.2.2.1.  Magnetic Bead-based

            11.2.2.2.  Non-magnetic Bead-based

    11.3. Market Value Forecast, by Technique, 2018–2030

        11.3.1. Nucleic Acid-based Techniques

        11.3.2. Protein-based Techniques

        11.3.3. Biosensor-based Techniques

    11.4. Market Value Forecast, by Application, 2018–2030

        11.4.1. Disease Testing

            11.4.1.1.  Infectious Disease Testing

            11.4.1.2.  Autoimmune Disease Testing

            11.4.1.3.  Other Diseases Testing

        11.4.2. Food Contamination Testing

        11.4.3. Research & Development

        11.4.4. Veterinary Disease Testing

    11.5. Market Value Forecast, by End-user, 2018–2030

        11.5.1. Pharmaceutical & Biopharmaceutical Companies

        11.5.2. Clinical Research Organizations

        11.5.3. Food & Beverage Industry

        11.5.4. Academic & Research Institutes

        11.5.5. Diagnostic Centers

        11.5.6. Others

    11.6. Market Value Forecast, by Country, 2018–2030

        11.6.1. U.S.

        11.6.2. Canada

    11.7. Market Attractiveness Analysis

        11.7.1.  By Assay Type

        11.7.2.  By Technique

        11.7.3.  By Application

        11.7.4.  By End-user

        11.7.5.  By Country

12.  Europe Multiplex Detection Immunoassays Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Assay Type, 2018–2030

        12.2.1.  Planar Assays

            12.2.1.1.  Blends Protein Arrays (multiplexed ELISA)

            12.2.1.2.  Antibody Arrays

        12.2.2.  Bead-based Assays

            12.2.2.1.  Magnetic Bead-based

            12.2.2.2.  Non-magnetic Bead-based

    12.3. Market Value Forecast, by Technique, 2018–2030

        12.3.1.  Nucleic Acid-based Techniques

        12.3.2.  Protein-based Techniques

        12.3.3.  Biosensor-based Techniques

    12.4. Market Value Forecast, by Application, 2018–2030

        12.4.1.  Disease Testing

            12.4.1.1.  Infectious Disease Testing

            12.4.1.2.  Autoimmune Disease Testing

            12.4.1.3.  Other Diseases Testing

        12.4.2.  Food Contamination Testing

        12.4.3.  Research & Development

        12.4.4.  Veterinary Disease Testing

    12.5. Market Value Forecast, by End-user, 2018–2030

        12.5.1.  Pharmaceutical & Biopharmaceutical Companies

        12.5.2.  Clinical Research Organizations

        12.5.3.  Food & Beverage Industry

        12.5.4.  Academic & Research Institutes

        12.5.5.  Diagnostic Centers

        12.5.6.  Others

    12.6. Market Value Forecast, by Country/Sub-region, 2018–2030

        12.6.1.  Germany

        12.6.2.  U.K.

        12.6.3.  France

        12.6.4.  Italy

        12.6.5.  Spain

        12.6.6.  Rest of Europe

    12.7. Market Attractiveness Analysis

        12.7.1.  By Assay Type

        12.7.2.  By Technique

        12.7.3.  By Application

        12.7.4.  By End-user

        12.7.5.  By Country/Sub-region

13.  Asia Pacific Multiplex Detection Immunoassays Market Analysis and Forecast

    13.1. Introduction

        13.1.1.  Key Findings

    13.2. Market Value Forecast, by Assay Type, 2018–2030

        13.2.1.  Planar Assays

            13.2.1.1.  Blends Protein Arrays (multiplexed ELISA)

            13.2.1.2.  Antibody Arrays

        13.2.2.  Bead-based Assays

            13.2.2.1.  Magnetic Bead-based

            13.2.2.2.  Non-magnetic Bead-based

    13.3. Market Value Forecast, by Technique, 2018–2030

        13.3.1.  Nucleic Acid-based Techniques

        13.3.2.  Protein-based Techniques

        13.3.3.  Biosensor-based Techniques

    13.4. Market Value Forecast By Application, 2018–2030

        13.4.1.  Disease Testing

            13.4.1.1.  Infectious Disease Testing

            13.4.1.2.  Autoimmune Disease Testing

            13.4.1.3.  Other Diseases Testing

        13.4.2.  Food Contamination Testing

        13.4.3.  Research & Development

        13.4.4.  Veterinary Disease Testing

    13.5. Market Value Forecast, by End-user, 2018–2030

        13.5.1.  Pharmaceutical & Biopharmaceutical Companies

        13.5.2.  Clinical Research Organizations

        13.5.3.  Food & Beverage Industry

        13.5.4.  Academic & Research Institutes

        13.5.5.  Diagnostic Centers

        13.5.6.  Others

    13.6. Market Value Forecast, by Country/Sub-region, 2018–2030

        13.6.1.  China

        13.6.2.  India

        13.6.3.  Japan

        13.6.4.  Australia & New Zealand

        13.6.5.  Rest of Asia pacific

    13.7. Market Attractiveness Analysis

        13.7.1.  By Assay Type

        13.7.2.  By Technique

        13.7.3.  By Application

        13.7.4.  By End-user

        13.7.5.  By Country/Sub-region

14.  Latin America Multiplex Detection Immunoassays Market Analysis and Forecast

    14.1. Introduction

        14.1.1.  Key Findings

    14.2. Market Value Forecast, by Assay Type, 2018–2030

        14.2.1.  Planar Assays

            14.2.1.1.  Blends Protein Arrays (multiplexed ELISA)

            14.2.1.2.  Antibody Arrays

        14.2.2.  Bead-based Assays

            14.2.2.1.  Magnetic Bead-based

            14.2.2.2.  Non-magnetic Bead-based

    14.3. Market Value Forecast, by Technique, 2018–2030

        14.3.1.  Nucleic Acid-based Techniques

        14.3.2.  Protein-based Techniques

        14.3.3.  Biosensor-based Techniques

    14.4. Market Value Forecast, by Application, 2018–2030

        14.4.1.  Disease Testing

            14.4.1.1.  Infectious Disease Testing

            14.4.1.2.  Autoimmune Disease Testing

            14.4.1.3.  Other Diseases Testing

        14.4.2. Food Contamination Testing

        14.4.3. Research & Development

        14.4.4. Veterinary Disease Testing

    14.5. Market Value Forecast, by End-user, 2018–2030

        14.5.1. Pharmaceutical & Biopharmaceutical Companies

        14.5.2. Clinical Research Organizations

        14.5.3. Food & Beverage Industry

        14.5.4. Academic & Research Institutes

        14.5.5. Diagnostic Centers

        14.5.6. Others

    14.6. Market Value Forecast, by Country/Sub-region, 2018–2030

        14.6.1.  Brazil

        14.6.2.  Mexico

        14.6.3.  Rest of Latin America

    14.7. Market Attractiveness Analysis

        14.7.1.  By Assay Type

        14.7.2.  By Technique

        14.7.3.  By Application

        14.7.4.  By End-user

        14.7.5.  By Country/Sub-region

15.  Middle East & Africa Multiplex Detection Immunoassays Market Analysis and Forecast

    15.1. Introduction

        15.1.1.  Key Findings

    15.2. Market Value Forecast, by Assay Type, 2018–2030

        15.2.1.  Planar Assays

            15.2.1.1.  Blends Protein Arrays (multiplexed ELISA)

            15.2.1.2.  Antibody Arrays

        15.2.2.  Bead-based Assays

            15.2.2.1.  Magnetic Bead-based

            15.2.2.2.  Non-magnetic Bead-based

    15.3. Market Value Forecast, by Technique, 2018–2030

        15.3.1. Nucleic Acid-based Techniques

        15.3.2. Protein-based Techniques

        15.3.3. Biosensor-based Techniques

    15.4. Market Value Forecast, by Application, 2018–2030

        15.4.1.  Disease Testing

            15.4.1.1.  Infectious Disease Testing

            15.4.1.2.  Autoimmune Disease Testing

            15.4.1.3.  Other Diseases Testing

        15.4.2.  Food Contamination Testing

        15.4.3.  Research & Development

        15.4.4.  Veterinary Disease Testing

    15.5. Market Value Forecast, by End-user, 2018–2030

        15.5.1. Pharmaceutical & Biopharmaceutical Companies

        15.5.2. Clinical Research Organizations

        15.5.3. Food & Beverage Industry

        15.5.4. Academic & Research Institutes

        15.5.5. Diagnostic Centers

        15.5.6. Others

    15.6. Market Value Forecast, by Country/Sub-region, 2018–2030

        15.6.1.  GCC Countries

        15.6.2.  South Africa

        15.6.3.  Rest of Middle East & Africa

    15.7. Market Attractiveness Analysis

        15.7.1.  By Assay Type

        15.7.2.  By Technique

        15.7.3.  By Application

        15.7.4.  By End-user

        15.7.5.  By Country/Sub-region

16. Competition Landscape

    16.1. Market Player - Competition Matrix (by tier and size of companies)

    16.2. Market Share Analysis, by Company, 2018

    16.3. Company Profiles

        16.3.1. F. Hoffmann-La Roche Ltd.

            16.3.1.1. Company Overview

            16.3.1.2. Company Financials

            16.3.1.3. Growth Strategies

            16.3.1.4. SWOT Analysis

        16.3.2. QIAGEN

            16.3.2.1. Company Overview

            16.3.2.2. Company Financials

            16.3.2.3. Growth Strategies

            16.3.2.4. SWOT Analysis

        16.3.3. Merck KGaA

            16.3.3.1. Company Overview

            16.3.3.2. Company Financials

            16.3.3.3. Growth Strategies

            16.3.3.4. SWOT Analysis

        16.3.4. Microsynth AG

            16.3.4.1. Company Overview

            16.3.4.2. Company Financials

            16.3.4.3. Growth Strategies

            16.3.4.4. SWOT Analysis

        16.3.5. Bio-Rad Laboratories

            16.3.5.1. Company Overview

            16.3.5.2. Company Financials

            16.3.5.3. Growth Strategies

            16.3.5.4. SWOT Analysis

        16.3.6. Thermo Fisher Scientific

            16.3.6.1. Company Overview

            16.3.6.2. Company Financials

            16.3.6.3. Growth Strategies

            16.3.6.4. SWOT Analysis

        16.3.7. Luminex Corporation

            16.3.7.1. Company Overview

            16.3.7.2. Company Financials

            16.3.7.3. Growth Strategies

            16.3.7.4. SWOT Analysis

        16.3.8. Becton, Dickinson and Company

            16.3.8.1. Company Overview

            16.3.8.2. Company Financials

            16.3.8.3. Growth Strategies

            16.3.8.4. SWOT Analysis

        16.3.9. Other Prominent Key Players

List of Tables

Table 01: Global Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Assay Type, 2018–2030

Table 02: Global Multiplex Detection Immunoassays Market Volume (Thousand Units) Forecast, by Planar Assays, 2018–2030

Table 03: Global Multiplex Detection Immunoassays Market Volume (Thousand Units) Forecast, by Bead-based Assays, 2018–2030

Table 04: Global Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Technique, 2018–2030

Table 05: Global Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 06: Global Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Disease Testing, 2018–2030

Table 07: Global Multiplex Detection Immunoassays Market Revenue (US$ Mn) Forecast, by End-user, 2018–2030

Table 08: Global Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 09: North America Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 10: North America Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Assay Type, 2018–2030

Table 11: North America Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Planar Assays, 2018–2030

Table 12: North America Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Bead-based Assays, 2018–2030

Table 13: North America Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Technique, 2018–2030

Table 14: North America Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 15: North America Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Disease Testing, 2018–2030

Table 16: North America Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 17: Europe Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 18: Europe Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Assay Type, 2018–2030

Table 19: Europe Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Planar Assays, 2018–2030

Table 20: Europe Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Bead-based Assays, 2018–2030

Table 21: Europe Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Technique, 2018–2030

Table 22: Europe Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 23: Europe Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Disease Testing, 2018–2030

Table 24: Europe Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 25: Asia Pacific Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 26: Asia Pacific Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Assay Type, 2018–2030

Table 27: Asia Pacific Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Planar Assays, 2018–2030

Table 28: Asia Pacific Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Bead-based Assays, 2018–2030

Table 29: Asia Pacific Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Technique, 2018–2030

Table 30: Asia Pacific Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 31: Asia Pacific Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Disease Testing, 2018–2030

Table 32: Asia Pacific Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 33: Latin America Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 34: Latin America Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Assay Type, 2018–2030

Table 35: Latin America Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Planar Assays, 2018–2030

Table 36: Latin America Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Bead-based Assays, 2018–2030

Table 37: Latin America Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Technique, 2018–2030

Table 38: Latin America Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 39: Latin America Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Disease Testing, 2018–2030

Table 40: Latin America Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 41: Middle East & Africa Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 42: Middle East & Africa Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Assay Type, 2018–2030

Table 43: Middle East & Africa Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Planar Assays, 2018–2030

Table 44: Middle East & Africa Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Bead-based Assays, 2018–2030

Table 45: Middle East & Africa Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Technique, 2018–2030

Table 46: Middle East & Africa Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 47: Middle East & Africa Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Disease Testing, 2018–2030

Table 48: Middle East & Africa Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by End-user, 2018–2030

List of Figures

Figure 01: Global Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, 2018–2030

Figure 02: Global Multiplex Detection Immunoassays Market Value Share, by Technique, 2019

Figure 03: Global Multiplex Detection Immunoassays Market Value Share, by Application, 2019

Figure 04: Global Multiplex Detection Immunoassays Market Value Share, by Assay Type, 2019

Figure 05: Global Multiplex Detection Immunoassays Market Value Share, by End-user, 2019

Figure 06: Global Multiplex Detection Immunoassays Market Value Share Analysis, by Type, 2019 and 2030

Figure 07: Global Multiplex Detection Immunoassays Market Attractiveness Analysis, by Type, 2020–2030

Figure 08: Global Multiplex Detection Immunoassays Market Revenue (US$ Mn), by Planar Assays, 2018–2030

Figure 09: Global Multiplex Detection Immunoassays Market Revenue (US$ Mn), by Bead-based Assays, 2018–2030

Figure 10: Global Multiplex Detection Immunoassays Market Value Share Analysis, by Technique, 2019 and 2030

Figure 11: Global Multiplex Detection Immunoassays Market Attractiveness Analysis, by Technique, 2020–2030

Figure 12: Global Multiplex Detection Immunoassays Market Revenue (US$ Mn), by Nucleic Acid-based Techniques, 2018–2030

Figure 13: Global Multiplex Detection Immunoassays Market Revenue (US$ Mn), by Protein-based Techniques, 2018–2030

Figure 14: Global Multiplex Detection Immunoassays Mar Revenue (US$ Mn), by Biosensor-based Techniques, 2018–2030

Figure 15: Global Multiplex Detection Immunoassays Market Value Share Analysis, by Application, 2019 and 2030

Figure 16: Global Multiplex Detection Immunoassays Market Attractiveness Analysis, by Application, 2020–2030

Figure 17: Global Multiplex Detection Immunoassays Market Value (US$ Mn), by Disease Testing, 2018–2030

Figure 18: Global Multiplex Detection Immunoassays Market Value (US$ Mn), by Food Contamination Testing, 2018–2030

Figure 19: Global Multiplex Detection Immunoassays Market Value (US$ Mn), by Research & Development, 2018–2030

Figure 20: Global Multiplex Detection Immunoassays Market Value (US$ Mn), by Veterinary Disease Testing, 2018–2030

Figure 21: Global Multiplex Detection Immunoassays Market Value Share Analysis, by End-user, 2019 and 2030

Figure 22: Global Multiplex Detection Immunoassays Market Attractiveness Analysis, by End-user, 2020–2030

Figure 23: Global Multiplex Detection Immunoassays Market Revenue (US$ Mn), by Pharmaceutical & Biopharmaceutical Companies, 2018–2030

Figure 24: Global Multiplex Detection Immunoassays Market Revenue (US$ Mn), by Clinical Research Organizations, 2018–2030

Figure 25: Global Multiplex Detection Immunoassays Market Revenue (US$ Mn), by Food & Beverage Industry, 2018–2030

Figure 26: Global Multiplex Detection Immunoassays Market Revenue (US$ Mn), by Academic & Research Institutes, 2018–2030

Figure 27: Global Multiplex Detection Immunoassays Market Revenue (US$ Mn), by Diagnostic Centers, 2018–2030

Figure 28: Global Multiplex Detection Immunoassays Market Revenue (US$ Mn), by Others, 2018–2030

Figure 29: Global Multiplex Detection Immunoassays Market Value Share Analysis, by Region, 2019 and 2030

Figure 30: Global Multiplex Detection Immunoassays Market Attractiveness Analysis, by Region, 2020–2030

Figure 31: North America Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 32: North America Multiplex Detection Immunoassays Market Value Share, by Country, 2019–2030

Figure 33: North America Multiplex Detection Immunoassays Market Attractiveness Analysis, by Country, 2019–2030

Figure 34: North America Multiplex Detection Immunoassays Market Value Share Analysis, by Assay Type, 2019 and 2030

Figure 35: North America Multiplex Detection Immunoassays Market Attractiveness Analysis, by Assay Type, 2020–2030

Figure 36: North America Multiplex Detection Immunoassays Market Value Share Analysis, by Technique, 2019 and 2030

Figure 37: North America Multiplex Detection Immunoassays Market Attractiveness Analysis, by Technique, 2020–2030

Figure 38: North America Multiplex Detection Immunoassays Market Value Share (%), by Application, 2019 and 2030

Figure 39: North America Multiplex Detection Immunoassays Market Attractiveness Analysis, by Application, 2020–2030

Figure 40: North America Multiplex Detection Immunoassays Market Value Share (%), by End-user, 2019 and 2030

Figure 41: North America Multiplex Detection Immunoassays Market Attractiveness Analysis, by End-user, 2020–2030

Figure 42: Europe Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 43: Europe Multiplex Detection Immunoassays Market Value Share, by Country/Sub-region, 2019–2030

Figure 44: Europe Multiplex Detection Immunoassays Market Attractiveness Analysis, by Country/Sub-region, 2019–2030

Figure 45: Europe Multiplex Detection Immunoassays Market Value Share Analysis, by Assay Type, 2019 and 2030

Figure 46: Europe Multiplex Detection Immunoassays Market Attractiveness Analysis, by Assay Type, 2020–2030

Figure 47: Europe Multiplex Detection Immunoassays Market Value Share Analysis, by Technique, 2019 and 2030

Figure 48: Europe Multiplex Detection Immunoassays Market Attractiveness Analysis, by Technique, 2020–2030

Figure 49: Europe Multiplex Detection Immunoassays Market Value Share (%), by Application, 2019 and 2030

Figure 50: Europe Multiplex Detection Immunoassays Market Attractiveness Analysis, by Application, 2020–2030

Figure 51: Europe Multiplex Detection Immunoassays Market Value Share (%), by End-user, 2019 and 2030

Figure 52: Europe Multiplex Detection Immunoassays Market Attractiveness Analysis, by End-user, 2020–2030

Figure 53: Asia Pacific Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 54: Asia Pacific Multiplex Detection Immunoassays Market Value Share, by Country/Sub-region, 2019–2030

Figure 55: Asia Pacific Multiplex Detection Immunoassays Market Attractiveness Analysis, by Country/Sub-region, 2019–2030

Figure 56: Asia Pacific Multiplex Detection Immunoassays Market Value Share Analysis, by Assay Type, 2019 and 2030

Figure 57: Asia Pacific Multiplex Detection Immunoassays Market Attractiveness Analysis, by Assay Type, 2020–2030

Figure 58: Asia Pacific Multiplex Detection Immunoassays Market Value Share Analysis, by Technique, 2019 and 2030

Figure 59: Asia Pacific Multiplex Detection Immunoassays Market Attractiveness Analysis, by Technique, 2020–2030

Figure 60: Asia Pacific Multiplex Detection Immunoassays Market Value Share (%), by Application, 2019 and 2030

Figure 61: Asia Pacific Multiplex Detection Immunoassays Market Attractiveness Analysis, by Application, 2020–2030

Figure 62: Asia Pacific Multiplex Detection Immunoassays Market Value Share (%), by End-user, 2019 and 2030

Figure 63: Asia Pacific Multiplex Detection Immunoassays Market Attractiveness Analysis, by End-user, 2020–2030

Figure 64: Latin America Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 65: Latin America Multiplex Detection Immunoassays Market Value Share, by Country/Sub-region, 2019–2030

Figure 66: Latin America Multiplex Detection Immunoassays Market Attractiveness Analysis, by Country/Sub-region, 2019–2030

Figure 67: Latin America Multiplex Detection Immunoassays Market Value Share Analysis, by Assay Type, 2019 and 2030

Figure 68: Latin America Multiplex Detection Immunoassays Market Attractiveness Analysis, by Assay Type, 2020–2030

Figure 69: Latin America Multiplex Detection Immunoassays Market Value Share Analysis, by Technique, 2019 and 2030

Figure 70: Latin America Multiplex Detection Immunoassays Market Attractiveness Analysis, by Technique, 2020–2030

Figure 71: Latin America Multiplex Detection Immunoassays Market Value Share (%), by Application, 2019 and 2030

Figure 72: Latin America Multiplex Detection Immunoassays Market Attractiveness Analysis, by Application, 2020–2030

Figure 73: Latin America Multiplex Detection Immunoassays Market Value Share (%), by End-user, 2019 and 2030

Figure 74: Latin America Multiplex Detection Immunoassays Market Attractiveness Analysis, by End-user, 2020–2030

Figure 75: Middle East & Africa Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 76: Middle East & Africa Multiplex Detection Immunoassays Market Value Share, by Country/Sub-region, 2019–2030

Figure 77: Middle East & Africa Multiplex Detection Immunoassays Market Attractiveness Analysis, by Country/Sub-region, 2019–2030

Figure 78: Middle East & Africa Multiplex Detection Immunoassays Market Value Share Analysis, by Assay Type, 2019 and 2030

Figure 79: Middle East & Africa Multiplex Detection Immunoassays Market Attractiveness Analysis, by Assay Type, 2020–2030

Figure 80: Middle East & Africa Multiplex Detection Immunoassays Market Value Share Analysis, by Technique, 2019 and 2030

Figure 81: Middle East & Africa Multiplex Detection Immunoassays Market Attractiveness Analysis, by Technique, 2020–2030

Figure 82: Middle East & Africa Multiplex Detection Immunoassays Market Value Share (%), by Application, 2019 and 2030

Figure 83: Middle East & Africa Multiplex Detection Immunoassays Market Attractiveness Analysis, by Application, 2020–2030

Figure 84: Middle East & Africa Multiplex Detection Immunoassays Market Value Share (%), by End-user, 2019 and 2030

Figure 85: Middle East & Africa Multiplex Detection Immunoassays Market Attractiveness Analysis, by End-user, 2020–2030

Figure 86: Global Multiplex Detection Immunoassays Market Share Analysis, by Company, 2019

Transparency Market Research Plus

Get a free copy if the report you purchased is updated within 90 days

Copyright © Transparency Market Research, Inc. All Rights reserved